Dextromethorphan/guaifenesin/phenylpropanolamine Interactions
There are 459 drugs known to interact with dextromethorphan/guaifenesin/phenylpropanolamine, along with 5 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 92 are major, 363 are moderate, and 4 are minor.
- View all 459 medications that may interact with dextromethorphan/guaifenesin/phenylpropanolamine
- View dextromethorphan/guaifenesin/phenylpropanolamine alcohol/food interactions (2)
- View dextromethorphan/guaifenesin/phenylpropanolamine disease interactions (5)
Most frequently checked interactions
View interaction reports for dextromethorphan / guaifenesin / phenylpropanolamine and the medicines listed below.
- Adakveo (crizanlizumab)
- Caprelsa (vandetanib)
- Droxia (hydroxyurea)
- Engerix-B Pediatric (hepatitis b pediatric vaccine)
- Evrysdi (risdiplam)
- Gazyva (obinutuzumab)
- Givlaari (givosiran)
- Imbruvica (ibrutinib)
- Ingrezza (valbenazine)
- Invirase (saquinavir)
- Leukeran (chlorambucil)
- Luvox (fluvoxamine)
- Mayzent (siponimod)
- Norditropin FlexPro (somatropin)
- Norvir (ritonavir)
- Ocrevus (ocrelizumab)
- Oxbryta (voxelotor)
- Panhematin (hemin)
- Phenurone (phenacemide)
- Protropin (somatrem)
- Rebif (interferon beta-1a)
- Recombinate (antihemophilic factor)
- Ritalin (methylphenidate)
- Rituxan Hycela (hyaluronidase / rituximab)
- Roferon-A (interferon alfa-2a)
- Serpazide (hydralazine / hydrochlorothiazide / reserpine)
- Strattera (atomoxetine)
- Torisel (temsirolimus)
- Tridione (trimethadione)
- Trizivir (abacavir / lamivudine / zidovudine)
Dextromethorphan/guaifenesin/phenylpropanolamine alcohol/food interactions
There are 2 alcohol/food interactions with dextromethorphan / guaifenesin / phenylpropanolamine.
Dextromethorphan/guaifenesin/phenylpropanolamine disease interactions
There are 5 disease interactions with dextromethorphan / guaifenesin / phenylpropanolamine which include:
Report options
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
